Immune Checkpoint Inhibitors and Inflammatory Myopathies: Data from the US Food and Drug Administration Adverse Event Reporting System

被引：0
|
作者：
Pundole, Xerxes [1 ]
Shah, Mohsin [1 ]
Abdel-Wahab, Noha [1 ]
Suarez-Almazor, Maria [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Sect Rheumatol & Clin Immunol, Dept Gen Internal Med, Houston, TX 77030 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
850
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Arrhythmic events associated with immune checkpoint inhibitors therapy: A real-world study based on the Food and Drug Administration Adverse Event Reporting System database
    Liu, Yunwei
    Chen, Yanxin
    Zeng, Zhimin
    Liu, Anwen
    CANCER MEDICINE, 2023, 12 (06): : 6637 - 6648
  • [32] Performance of subgrouped proportional reporting ratios in the US food and drug administration (FDA) adverse event reporting system
    Dauner, Dan
    Zhang, Rui
    Adam, Terrence
    Leal, Eleazar
    Farley, Joel F.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 598 - 598
  • [33] Empirical estimation of under-reporting in the US Food and Drug Administration Adverse Event Reporting System (FAERS)
    Alatawi, Yasser M.
    Hansen, Richard A.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (07) : 761 - 767
  • [34] Performance of subgrouped proportional reporting ratios in the US Food and Drug Administration (FDA) adverse event reporting system
    Dauner, Daniel G.
    Zhang, Rui
    Adam, Terrence J.
    Leal, Eleazar
    Heitlage, Viviene
    Farley, Joel F.
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (07) : 589 - 597
  • [35] Comparisons of adverse event reporting for colistin versus polymyxin B using the US Food and Drug Administration Adverse Event Reporting System (FAERS)
    Cong Bang Truong
    Durham, Spencer H.
    Qian, Jingjing
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (05) : 603 - 609
  • [36] Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System
    Serebruany, Victor L.
    Hall, Trygve S.
    Atar, Dan
    Agewall, Stefan
    Kim, Moo Hyun
    Geudelin, Bernard
    Lomakin, Nikita
    Marciniak, Thomas A.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2019, 5 (04) : 210 - 215
  • [37] An Ecological Study on Consumer Adverse Event Reporting to the US Food and Drug Administration
    Munoz, M.
    Dal Pan, G.
    Xiao, H.
    Delcher, C.
    Wei, J.
    Kortepeter, C.
    Winterstein, A.
    DRUG SAFETY, 2018, 41 (11) : 1132 - 1132
  • [38] The safety of niacin in the US Food and Drug Administration Adverse Event Reporting database
    Alsheikh-Ali, Alawi A.
    Karas, Richard H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8A): : 9B - 13B
  • [39] Novel Adverse Event of Atezolizumab: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Ahmed, Abdul Mannan Faruk
    Maheswari, Eswaran
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 306 - 306
  • [40] Drug-induced tooth discoloration: An analysis of the US food and drug administration adverse event reporting system
    Wang, Jun
    Zou, Dongna
    Li, Yuchao
    Liu, Pingping
    Guo, Chenyu
    FRONTIERS IN PHARMACOLOGY, 2023, 14
12345